1-Isobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

3-(3-Bromophenyl)pentanedioic acid, 97+%, 100mg

(1S)-1-(FURAN-2-YL)ETHAN-1-AMINE, 95.0%, 250mg

5,6-Dibromo-1H-indole, 97%, 250mg

3-(1-((3,3-Diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride, 99+%, 5g

tert-Butyl ((1S,2S)-2-aminocyclopentyl)carbamate, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-cyclopentylacetic acid, 97%, 1g

6-(1H-pyrazol-1-yl)pyridazine-3-carboxylic acid, 95.0%, 2.5g

2-Bromo-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 5g

Thalidomide-NH-C4-NH-Boc, 10mg

Soluzione di tetracloroplatinato(II) di sodio 10 g

PROPANE 1,2-CYCLIC SULFATE, 98.0%, 5g

(3R)-(+)-3-(Trifluoroacetamido)pyrrolidine hydrochloride, 98.0%, 100mg